Previous reports indicate that the cancer-specific promoters of RAD51 and RAD51C, two critical HR factors, hold great potential for cancer diagnosis and treatment17,18, but whether the two promoters are suitable for transcriptionally targeting every type of tumor has not been analyzed. The gene discussed is RAD51C; the disease is cancer.